Diabetes Care Devices Market - Segmentation, Major Players & Geographical Analysis

According to the new market research report “Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) – Forecast to 2025″, published by MarketsandMarkets™, the Diabetes Care Devices ((BRIC) Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.

Recent Developments:

• In February 2020, Abbott (US) received US FDA approval for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals.
  
  
• In February 2020, Insulet signed a commercialization agreement with DexCom, Inc. (US) to allow its current and future CGM systems to connect to the former’s tubeless insulin pump system, OMNIPOD Horizon system.
  
  
• In April 2020, Ypsomed (Switzerland) entered into a partnership with DexCom, Inc. (US) to integrate its mylife YpsoPump data with DexCom’s G6 CGM sensors to form a hybrid closed-loop system.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375

The Factors such as the increasing diabetic population, rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.

The blood glucose monitoring systems segment is estimated to dominate the diabetes care devices market in 2020

Based on type, the diabetes care devices (BRIC) market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020. The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.

Self/home healthcare is projected to witness the highest CAGR in the diabetes care devices (BRIC) market during the forecast period

Based on end user, the diabetes care devices market has been segmented into hospitals & specialty clinics and self/home healthcare. The self/home healthcare segment is estimated to hold the largest share in 2020. This segment is also projected to grow at the highest CAGR during the forecast period. The rapid growth of the segment is attributed to the increasing awareness of diabetes self-monitoring and management, increasing recommendations from physicians for home healthcare for diabetes, and the increasing utility of home-based diabetes care devices to provide real-time insights regarding the condition due to the technological advancements of these systems.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375

China to hold the largest share in the market in 2020, followed by India

China is projected to hold the largest share in the diabetes care devices (BRIC) market during the forecast period. This can be attributed to the sharp increase in diabetes in the country, favorable national health strategies, and government-led endorsements of medical device companies.

The prominent players in the diabetes care devices market include Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt. Ltd. (India), Ypsomed Holdings AG (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan)

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=375

Surface Disinfectant Market 2022 - Segments, Trends, Share and Forecast Growth

According to the new market research report “Surface Disinfectant Market by Composition (Quaternary Ammonium, Alcohols, Chlorine, Hydrogen Peroxide), Type (Liquids, Sprays, Wipes), Application (Surface, Instrument), End User (Hospitals, Diagnostic and Research Labs) – Global Forecast to 2025″, published by MarketsandMarkets™, is projected to reach USD 3.6 billion by 2025 from USD 3.1 billion in 2020, at a CAGR of 3.0% from 2020 to 2025.

Driver: Rising number of stringent regulations for the use of surface disinfectants;

Rising number of stringent regulations focus on the development of suitable policies for housekeeping services, which puts a premium on good housekeeping and sanitation. Such regulatory guidelines will help in improving the regular usage of surface disinfectants across healthcare settings.

Opportunity: Increasing healthcare expenditure and focus in emerging economies;

Emerging economies, such as India, Brazil, and South Africa, provide significant opportunities for players in the sterilization and disinfection markets. Emerging economies in the APAC region present lucrative investment opportunities for multinational infection control companies to offshore their business operations to these markets.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2312860

The growth of this market is majorly driven by the increasing prevalence of hospital-acquired infections (HAIs) globally, presence of stringent regulations for the use of surface disinfectants (in hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, and research laboratories), and advancements in surface disinfectants.

Alcohols segment accounted for the largest share of the surface disinfectants market.

On the basis of composition, the market is segmented into alcohols, chlorine compounds, quaternary ammonium compounds, hydrogen peroxide, peracetic acid, and other compositions. In 2019, the alcohols segment accounted for the largest market share. The high use of alcohols on hard surfaces in hospitals and laboratories is driving the growth of this segment. Other segments, such as hydrogen peroxide and peracetic acid are expected to have higher growth rates due to their growing acceptance in surface disinfectant formulations.

Liquids segment accounted for the largest share of the of the surface disinfectants market.

On the basis of type, the market is segmented into liquids, wipes, and sprays. The liquids segment accounted for the largest market share in 2019. This can primarily be attributed to the wide usage of these disinfectants, especially in emerging and underdeveloped countries, due to their low cost.

The hospital settings segment is expected to dominate the market in 2020.

By end user, the surface disinfectants market is segmented into hospital settings, diagnostic laboratories, pharmaceutical & biotechnology companies, and research laboratories. In 2019, hospital settings accounted for the largest share of the market. The large share of this segment can be attributed to factors, such as the high prevalence of infections in hospitals, the increase in hospital reimbursements for surgeries performed in hospitals, and growing patient volume in these healthcare settings.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231286043

The surface disinfection segment dominated the market in 2019.

The surface disinfectants market, by application, is segmented into surface disinfection, instrument disinfection, and other applications. In 2019, the surface disinfection segment accounted for the largest share of the market. The large share of this segment can primarily be attributed to the large volume of disinfectants required to clean in-house surfaces in healthcare settings.

Based on region, the surface disinfectant market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America commanded the largest share of the market. The large share of this market segment can be attributed majorly to the high prevalence of HAIs and the presence of stringent infection control regulations in the region.

The major players operating in this surface disinfectant market are 3M Group (US), Cantel Medical Corporation (US), The Clorox Company (US), Ecolab Inc. (US), Procter & Gamble (US), Reckitt Benckiser Group plc. (UK), Diversey, Inc. (US), STERIS plc (US), CarrollCLEAN (US), Metrex Research, LLC. (US), Whiteley Corporation (Australia), GOJO Industries, Inc. (US), PAUL HARTMANN AG (Germany), Medline Industries, Inc. (US), Pharmax Limited (Canada), PDI Inc. (US), Betco (US), GESCO Healthcare Pvt. Ltd. (India), MEDALKAN (Greece), Ruhof (US), Contec Inc. (US), Cetylite, Inc. (US), Micro-Scientific, LLC (US), Pal International (UK), and BHC, Inc. (US).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=231286043

Prefilled Syringes Market Size, Share, Outlook, Industry Analysis Report

According to the new market research report “Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) – Global Forecast to 2025″, published by MarketsandMarkets™, is estimated to be USD 5.6 billion in 2020 and projected to reach USD 8.6 billion by 2025, at a CAGR of 9.0%.

Opportunity: Growing  healthcare infrastructure across emerging markets;

Emerging countries continue to suffer from insufficient healthcare funding, which adversely affects access to healthcare, quality, and, ultimately, the health status of citizens. According to the World Bank, approximately 400 million people lack access to essential healthcare services, mostly in Africa and South Asia. Furthermore, accelerating medical inflation, i.e., the cost of medical treatments and a higher prevalence of non-communicable lifestyle-related diseases such as cancer, diabetes, or cardiac syndromes, have resulted in funding gaps.

According to a report published by Geneva Association, in the last two decades, the share of total aggregate global expenditure on healthcare in GDP has increased from about 8% to almost 10%, or an estimated USD 8 trillion per annum, which is driven by the accelerating cost of medical treatment, expanding treatment options and increasing customer demands. Moreover, the Global Burden of Disease Health Financing Collaborator Network (2017) estimates that global spending on health will almost triple to USD 24 trillion by 2040 with upper-middle-income countries are estimated to show the fastest increase at an average of 5.3% per year. This growth could be attributed to continued growth in GDP and the rise of the middle class and government spending.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=16618331

The Rising target disease population, rapid growth in generic products, rising adoption of self-medication and digitalization, affordable cost with increased efficiency, and technological advancements are the major factors driving the growth of the market. Furthermore, growing initiatives undertaken by leading market players to establish production facilities in both mature and developing markets are the key factors driving the growth of the prefilled syringes industry.

The Prefilled Syringes Market includes major Tier I and II suppliers like Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), and West Pharmaceutical Services, Inc. (US), and Nipro Corporation (Japan). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Routine care for chronic diseases is an ongoing challenge amidst the global COVID-19 pandemic due to the change in routine care to virtual communication. Diabetes, chronic obstructive pulmonary disease, and hypertension were the most impacted conditions due to a reduction in access to care. Furthermore, currently, most global healthcare resources are focused on coronavirus disease (COVID-19), and this resource reallocation is expected to disrupt the continuum of care for patients with chronic diseases.

Increasing adoption of self-administered injectable drugs is expected to result in the segment occupying the majority of the market share

The conventional Prefilled Syringes Market is estimated to have the largest market share by value. Growth of this segment can be attributed to the the advantages offered, such as safe administration, ease of use for both healthcare professionals and end users, reduced risk of contamination of the product, less waste of costly API, ease of manufacturing, improved dosing accuracy, and enhanced product differentiation when compared to vials is expected to drive the market growth.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=16618331

Plastic Prefilled Syringes estimated to be the fastest-growing market

Plastic prefilled syringes are estimated to be the fastest-growing segment in the Prefilled Syringes Market. The growth of this segment can be attributed to the rising development of newer polymers (which possess various physical and chemical properties such as high heat & break resistance, tolerance of freeze-drying & liquid nitrogen exposure, high transparency, and solvent resistance.

Europe is estimated to be the largest market due to the rising prevalence of chronic diseases, growth of the biologics and biosimilars market, technological advancements, geographical expansion by key manufacturers, aging population, and high adoption of self-injection devices are driving the demand for self-injectable prefilled syringes.

Asia Pacific likely to emerge as the largest Prefilled Syringes Market.

Asia Pacific is estimated to be the fastest-growing market for prefilled syringes during the forecast period. The Asia Pacific market is driven principally by the increasing demand for self-administered treatments, high penetration of self-injection devices, growing aging population, increasing prevalence of diabetes, and huge patient population.

Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), and West Pharmaceutical Services, Inc. (US) are the key players in the global Prefilled Syringes Market

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=16618331

Rapid Microbiology Testing Market Size, Share, Growth Drivers, Industry Analysis and Application Forecast

According to the new market research report “Rapid Microbiology Testing Market by Product (Reagents, Kits, Automated Identification System, PCR, Mass Spectrometry), Method (Growth, Nucleic Acid, Viability), Applications (Clinical Diagnosis, Pharma, Environmental) – Global Forecast to 2026″, published by MarketsandMarkets™, the global Rapid Microbiology Instruments Market is projected to reach USD 6.7 billion by 2026 from USD 4.2 billion in 2021, at a CAGR of 9.4%.

Driver: Increasing incidence of infectious disease and cancer;

The incidence of various infectious diseases such as HIV, tuberculosis, malaria, and pneumonia has increased. With a rise in the global burden of these diseases, the demand for rapid microbiology techniques for faster and accurate microbial screening, identification, and susceptibility testing against pathogens is expected to witness significant growth during the forecast period

Opportunity: Growth opportunities in emerging countries;

Emerging economies such as India, South Korea, Brazil, and Mexico offer significant growth opportunities to players operating in the rapid microbiology testing market. This can be attributed to the low regulatory barriers, improvements in healthcare infrastructure, growing patient population, rising prevalence of infectious diseases, and rising healthcare expenditure. Moreover, the regulatory policies in some of these countries are more adaptive and business-friendly than those in developed countries has drawn key players in the rapid microbiology testing market to focus on emerging countries.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=31548521

The Increasing incidence of infectious disease and cancer, technological advancements in rapid microbiology testing, increased funding for R&D and increased focus on the early detection of infectious disease are among the other factors. Emerging economies such as China, India, and Japan are providing lucrative opportunities for the players operating in the market.

The cardiac Instruments segment accounted for the largest share of the rapid microbiology testing market 2020

Based on product, the Rapid microbiology instruments market is segmented into instruments, reagents and kits, and consumables. The instruments segment accounted for the largest share of the market in 2020. Factors such as technological advancements, increasing incidence of infectious disease and cancer and increased focus on the early detection of infectious disease are contributing to the growth of this market.

Nucleic acid-based rapid microbiology testing segment to register the highest growth rate during the forecast period

The rapid microbiology testing market is segmented into growth-based, nucleic acid-based, viability-based, cellular component-based, and another rapid microbiology testing. In 2020, the nucleic acid-based segment accounted for the highest growth rate. Factors such as the increased focus on early detection of infectious disease and rising incidence of infectious diseases and cancer.

The clinical disease diagnostics segment accounted for the largest share of the Rapid Microbiology Instruments Market in 2020

Based on applications, the rapid microbiology testing market has been segmented into clinical disease diagnosis, food and beverage testing, pharmaceutical and biological drug testing, environmental testing, cosmetics, and personal care products testing, research applications, and other applications. In 2020, the clinical disease diagnostics segment accounted for the largest share of the market. The increasing incidence of infectious disease and cancer is driving this segments growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=31548521

North America is the largest regional market for rapid microbiology testing market

The global market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the market. The large share of this region can be attributed to the increased funding on R&D and technological advancements in the US and Canada.

The major players operating in this rapid microbiology testing market are Abbott Laboratories, Inc. (US), Becton, Dickinson and Company (US), bioMérieux SA (France), Bruker Corporation (US), Charles River Laboratories International, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), NEOGEN Corporation (US), Quidel Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), Don Whitley Scientific Limited (UK), Rapid Micro Biosystems, Inc. (US), Vivione Biosciences, LLC (US), Gradientech (Sweden), rqmicro AG (Switzerland), Bactest Ltd. (US), Colifast (Norway), Serosep Ltd. (Ireland), Biosensia (Ireland), Solus Scientific Solutions Ltd. (Scotland), LubioScience GmbH (Scotland), Euroclone SpA (Italy), CorDx (US), and R-Biopharm AG (Germany).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=31548521

Cell Culture Media Market - Global Industry Leaders & Growth Strategies Adopted

According to the new market research report "Cell Culture Media Market by Type(Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application(Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User(Pharma, Biotech) - Global Forecast to 2026", published by MarketsandMarkets™, is projected to reach USD 10.3 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 16.0% between 2021 and 2026.

Browse in-depth TOC on "Cell Culture Media Market"
314 – Tables
41 – Figures
303 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97468536

The global cell culture media market is expected to grow at a CAGR of 16.0% during the forecast period. The growth of this market is majorly driven by the rising R&D spending in pharmaceutical companies, emerging cell culture technologies for cell-based vaccines, increasing demand for monoclonal antibodies, growth in stem cell research, the launch of new cell culture media by market players, and the growing focus on personalized medicine. On the other hand, expensive cell biology research products and ethical concerns regarding cell biology research are expected to hinder the growth of this market.

The serum-free media segment accounted for the largest share of the type segment in the cell culture media market in 2020.

Based on type, the market is segmented into serum-free media, classical media & salts, stem cell culture media, specialty media, chemically defined media, and other cell culture media. In 2020, the serum-free media segment accounted for the largest share of the market. This can be attributed to the advantages of serum-free media over other types of media, including consistent performance, increased growth & productivity, better control over physiological responsiveness, and reduced risk of contamination by serum-borne adventitious agents in cell culture.

The biopharmaceutical production segment accounted for the largest share of the application segment in the cell culture media market in 2020.

Based on application, the market is categorized into biopharmaceutical production, diagnostics, drug discovery & development, tissue engineering & regenerative medicine, and other applications. The biopharmaceutical production segment is further divided into monoclonal antibody production, vaccine production, and other therapeutic protein production. The tissue engineering & regenerative medicine segment is further divided into cell & gene therapy and other tissue engineering & regenerative medicine applications. The biopharmaceutical production segment is estimated to grow at the highest CAGR of 17.5% during the forecast period. The high growth of this segment is attributed to the commercial expansion of major pharmaceutical and biotechnology companies, the increasing demand for mAbs, and the growing regulatory approvals for the production of cell culture-based vaccines.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=97468536

The Asia Pacific region is the fastest-growing region of the cell culture media market in 2020.

Based on the region, the global market has been segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific market is estimated to register the highest CAGR during the forecast period. The growing geriatric population, favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian economies are the major factors contributing to the growth of the cell culture media market in the Asia Pacific.

Key players in the cell culture media market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), and Sartorius AG (Germany), Corning Incorporated (US).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=97468536

Virology Specimen Collection Market - Emerging Industry Trends and Global Future Forecast

According to the new market research report “Virology Specimen Collection Market by Product (Viral Transport Media, Swabs, Blood Collection Kits, Specimen Collection Tubes), Sample Type (Blood, Cervical, Nasal, Nasopharyngeal, Throat, Oral), Region-Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 5.4 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of -0.6%.

Driver: Rising prevalence of viral diseases and emergence of newer pathogens;

The Zika virus and Babesia outbreaks, alongside announcements for their inclusion in virology specimen collection tests, indicate the need for innovation in virology specimen collection technologies, consumables, and instruments. Other countries have also undertaken initiatives to check for new and emerging diseases. For example, the prevalence of malaria in African regions and the possibility of mosquito-borne transfer of Zika has resulted in mandates for Zika virus screening in the region.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150226807

The Rising number of blood donations are among the factors. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the market.

In 2020, virology transport media segment accounted for the largest share of the virology specimen collection market;

The virology specimen collection market is segmented into viral transport media, swabs, blood collection kits, and specimen collection tubes. The viral transport media accounted for the largest share of the virology specimen collection market in 2020, mainly due to the rising number of blood donations, and the emergence of new pathogens.

In 2020, nasopharyngeal sample segment accounted for the largest share in the market;

The virology specimen collection market is segmented blood, cervical, nasal, nasopharyngeal, throat, oral, and other (conjunctiva, feces, nasopharyngeal aspirate or wash, urethral, urine samples, semen, sputum, and cerebrospinal fluid) samples. In 2020, nasopharyngeal samples accounted for the largest share of the virology specimen collection market. The large share of this segment can be attributed primarily due to the fast detection of transfusion transmissible infection (TTIs), and the increasing prevalence of HPV-related cancers (all cervical cancers) & human papillomavirus (HPV).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=150226807

The global Virology Specimen Collection Market is segmented into four major regions, namely, North America, Europe, the Asia Pacific and Rest of the World. In 2020, North America accounted for the largest share of the market. The large share of this region can be attributed to increasing number of blood donations in the region.

The major players operating in virology specimen collection market are Becton, Dickinson and Company (US), Quidel Corporation (US), Thermo Fisher Scientific, Inc. (US), Trinity Biotech (Ireland), Titan Biotech, Ltd. (India), Diasorin SA (Italy), Vircell S.L. (Spain), Copan Italia S.p.A. (Italy), Puritan Medical Products, Co. (Guilford, ME) and Hardy Diagnostics (US).

Becton, Dickinson and Company is one of the leading company in the market. BD manufacturers and markets laboratory equipment, diagnostic products, and medical instrument systems & reagents. The company operates its business through three segments—BD Medical, BD Life Sciences, and BD Interventional. In June 2020, BD announced the CE Mark and market launch of the BD Vacutainer UltraTouch Blood collection set.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=150226807

Electronic Trial Master File Systems Market 2021 | Share, Trend, Segmentation and Forecast to 2024

According to the new market research report “Electronic Trial Master File (eTMF) Systems Market by Component (Services, Software), End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations), Delivery Mode (On-Premise, Cloud-Based), and Region – Global Forecast to 2024″, published by MarketsandMarkets™, the eTMF systems market is projected to reach USD 1.8 billion by 2024 from USD 1.0 billion in 2019, at a CAGR of 12.7%

Report Objectives Coverd in Research;

- To define, describe, segment, and forecast the eTMF systems market by delivery mode, component, end-user, and region

- Will provide detailed information about the factors (such as drivers, restraints, opportunities, and challenges) influencing market growth

- To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market

- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

- To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94357456

The Factors such as rising adoption of eTMF systems, rising number of clinical trials, partnerships between biopharma companies and CROs, rising funding to support clinical trials, and the growth in the R&D spending by pharma & biotech companies are driving the growth of the eTMF Systems Market.

The cloud-based eTMF to register the highest CAGR during the forecast period

Based on delivery mode, the eTMF Systems Market is segmented into on-premise and cloud-based eTMF. The cloud-based eTMF segment is expected to register the highest CAGR during the forecast period. Growth in this segment can be attributed to the comparatively lower capital expenses & operational costs incurred in this model, alongside its scalability, flexibility, and affordability.

Cloud-based solutions help healthcare organizations share and integrate information from different locations, making the process of data gathering seamless. Moreover, these solutions are comparatively affordable to install and maintain as compared to on-premise solutions, thus contributing to the high growth and popularity of the cloud-based delivery model.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94357456

North America dominated the Electronic Trial Master File Systems Market  in 2018; this trend to continue during the forecast period

Geographically, the eTMF Systems Market is divided into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The North American market accounted for the largest share of the Electronic Trial Master File (eTMF) Systems Market in 2018, primarily due to the increasing government funding for clinical research and a large number of clinical trials. Several major global players are also based in the US, owing to which the country has become a center of innovation in the eTMF Systems Market

Veeva Systems (US), Oracle Corporation (US), Phlexglobal Limited (UK), TransPerfect Global Inc. (US), Aurea Software (US), LabCorp (US), ePharmaSolutions (US), Wingspan Technology, Inc. (US), MasterControl (US), SureClinical, Inc. (US), Dell EMC (US), Paragon Solutions (US), PharmaVigilant (US), Mayo Clinic (US), Database Integrations, Inc. (US), CareLex (US), Ennov (France), Forte Research (US), Freyr (US), Montrium (US), NCGS Inc. (US), SAFE-BioPharma (US), SterlingBio Inc. (US), BIOVIA Corp. (US), and arivis AG (Germany) are the key players in the Electronic Trial Master File (eTMF) Systems Market.

Veeva Systems was the leading player in the electronic trial master file (eTMF) systems market in 2018. The company’s dominant position can be attributed to its solution, Veeva Vault eTMF. The company focuses on various inorganic and organic growth strategies such as solution deployments and expansions to maintain and enhance its market share. In the last three years, Veeva Systems has deployed its solutions at more than ten pharmaceutical companies, CROs, and other sites in the US to expand its user base with the development of innovative solutions. The company also has a strategic focus on expansions in growing emerging markets, such as the Middle East and Asia.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=94357456

Women's Health Care Market - Growth by Top Key Players, Application and Forecast Analysis

According to the new market research report “Women’s HealthCare Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) – Global forecast to 2024″, published by MarketsandMarkets™, is projected to reach USD 17.8 billion by 2024 from USD 9.6 billion in 2019, at a CAGR of 13.2% during the forecast period.

Report Objectives:

- To define, describe, and forecast the women’s healthcare market on the basis of drug, application, and region

- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, opportunities, and challenges)

- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders

- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa

- To profile the key players and analyze their market shares and core competencies

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136585329

The Women’s Health Care Market growth is largely driven by the growing incidence of chronic health conditions among women, government initiatives to curb population growth, growing demand for contraceptives to prevent unintended pregnancies, and the growing focus on R&D by key players for the development of advanced products. On the other hand, the reluctance to use contraceptives is a major factor limiting the Women’s HealthCare Market growth.

Prolia is the largest and fastest-growing segment of the market.

Based on drug, the market is segmented into EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL, and ORTHO-TRI-CY LO (28). Prolia is the largest and fastest-growing segment of the market. Prolia has shown a considerable year-on-year growth primarily due to increasing unit demand. Prolia has witnessed positive market growth owing to the increasing prevalence of postmenopausal osteoporosis in the US.

The postmenopausal osteoporosis segment is expected to grow at the highest CAGR during the forecast period.

On the basis of application, the market is segmented into hormonal infertility, postmenopausal osteoporosis, endometriosis, contraceptives, menopause, PCOS, and other applications. The postmenopausal osteoporosis segment is expected to grow at a higher CAGR during the forecast period. The growing prevalence of postmenopausal osteoporosis and a high risk of osteoporosis fractures are the prime factors that contribute towards the large share of this segment. Furthermore, the focus of pharmaceutical players on providing effective drugs for postmenopausal osteoporosis also supports the growth of this segment. The postmenopausal osteoporosis segment also holds the largest share of the market owing to these factors.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=136585329

North America commanded the largest share of the Women’s Health Care Market in 2019.

In 2018, North America was the largest and the fastest-growing regional market for women’s healthcare. The increasing median age of first-time pregnancies and the growing prevalence of PCOS and postmenopausal osteoporosis are the factors responsible for the growth of this regional segment. Furthermore, the growing awareness and understanding regarding contraceptives among American women, easy access to modern contraception as compared to developing countries, and increased healthcare spending also support the growth of this market.

The prominent players in the global Women’s Health Care Market include Bayer AG (Germany), Allergan (Dublin), Merck & Co. (US), Pfizer Inc. (US), Amgen (US), Agile Therapeutics Inc. (US), Ferring Pharmaceuticals (US), Mylan N.V. (US), Lupin (India), Blairex Laboratories (US), Apothecus Pharmaceutical (US), Eli Lilly And Company (US), Novartis AG (Switzerland), and Johnson & Johnson (US).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=136585329

Foot and Ankle Devices Market worth $5.3 billion by 2025 – Exclusive Report by MarketsandMarkets™

According to the new market research report “Foot and Ankle Devices Market by Product (Implants, Plates, Screw, Wires, Internal Fixators, Braces, Prosthesis (SACH, Single/Multi-Axial)), Application (Rheumatoid Arthritis, Osteoporosis, Hammertoe), Enduser (Hospital, ASCs) – Global Forecasts to 2025″, published by MarketsandMarkets™, is projected to reach USD 5.3 billion by 2025 from USD 3.9 billion in 2020, at a CAGR of 6.4% during the forecast period.

Opportunity: Marketing, promotion and branding initiatives undertaken by major product manufacturers;

Major product manufacturers are undertaking strategic initiatives to increase their brand visibility and product awareness among key end users (such as medical professionals, patients, and physiotherapists) across major healthcare markets worldwide. Company operating in foot and ankle devices market are opting for hybrid distribution strategy as per which distribution takes place both by distribution channel and through partnership with global orthopedic companies. Foot and ankle devices company has also adopted consignment model, accoding to which company first places the systems with its customers and sales are made according to the implementation of implants. Such initiatives undertaken by major product manufacturers are expected to increase their brand awareness among target end-users as well as sensitize them about their role in preventive care.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=845

The growth of Foot and Ankle Implants Market is mainly driven by the growing number of hospitals across major markets, increasing awareness about complication related to foot and ankle related to osteoarthritis and diabetes coupled with the increasing adoption of bracing and support devices. Moreover, rising R&D investments by the key players operating in the market to develop advanced foot and ankle devices coupled with growing funding & grants for commercialization and development of foot and ankle devices are other important factors to drive the market growth in the near future.

The Internal fixation devices sub segment of fixation devices products to hold major market share by 2025

Based on the product, the foot and ankle devices market is segmented into orthopedic implants and devices, prostheses, and bracing and support devices. The orthopedic implants and devices products segment is further divided into Fixation devices, joint implants, and soft tissue orthopedic devices. Among the fixation devices products, the internal fixation devices segment held a major share of the market in 2019. Internal fixation devices include screws, plates, wires & pins, and fusion nails. These devices are used in foot and ankle injuries resulting from conditions such as trauma, neurological disorders, bunions, arthritis, and osteoporosis. Internal fixation devices are more effective and reduce the incidences of malunion or nonunion of the injured bones. These implants are made of stainless steel, titanium, cobalt, or chrome. The wide applications of Internal fixation devices devices in foot and ankle injuries and disorders management are a major factor contributing to the growth of this market segment.

The trauma and hair line fracture segment is expected to account for the largest share of the foot and ankle devices market in 2019

Based on application, segmented into the rheumatoid arthritis & osteoarthritis, trauma and hairline fractures, diabetic foot diseases, neurological disorders, ligament injuries, hammertoe, and other applications. Among these, the trauma and hairline fractures sub-segment dominated the market in 2019. The major share of the segment is attributed to the rising sport injuries in developing as well as developed countries. As of 2018, 265 million people participated in soccer across the globe, according to Fédération Internationale de Football Association (FIFA). New products have been introduced in the market that allow for easier reconstruction for sport injuries.

The hospital segment is expected to register the highest growth rate during the forecast period

Based on end user, the foot and ankle devices market has been segmented into the hospitals, ambulatory surgery centers, orthopedic clinics and rehabilitation centers. Significant market growth and large share of hospital segment can primarily be attributed to the presence of advanced surgical wards and emergency wards in hospitals and the increasing number of surgical procedures.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=845

North America is expected to dominate the global patient monitoring market in 2019

North America, comprising the US and Canada, accounted for the largest share of the foot and ankle devices market in 2019. Increasing number of clinical trials validating foot and ankle devices and a growing number of approvals forfoot and ankle devices are the major factors driving market growth in North America. Customers in North America are moving towards ambulator surgical centers, which is increasing decal centers, which is increasing demand for foot and ankle devices. This trend will have a positive impact on the foot devices market.

DePuy Synthes Companies (US), Stryker Corporation (US), Zimmer Biomet Holdings, Inc (US), Smith & Nephew plc (UK), Arthrex Inc (US), Integra LifeSciences Holdings Corporation (US), DJO Finance, LLC (US), CONMED Corporation (US), Össur HF (Iceland), Orthofix Medical Inc. (US), Medartis AG (Switzerland), Acumed LLC (US), Extremity Medical (US), aap Implantate AG (Germany), Ottobock SE & Co. KGaA (Germany), Ortho Solutions UK Ltd. (UK), Vilex in Tennessee, Inc. (US), Advanced Orthopaedic Solutions (US), Fillauer LLC (US), and Groupe FH Ortho (France),among others are some of the major players operating in the global foot and ankle devices market.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=845

 

Particle Counters Market future growth probabilities and Comprehensive Analysis & Key Players

According to the new market research report “Particle Counter Market by Type (Airborne, Liquid), Application (Cleanroom Monitoring, Contamination Monitoring of Liquids, IAQM), End User (Life Sciences & Medical Devices, Semiconductor, Automotive), Region – Global Forecast to 2025″, published by MarketsandMarkets™, is projected to grow at a CAGR of 9.9% during the forecast period, to reach USD 554 million by 2025 from USD 346 million in 2020.

Driver: Regulations and standards for cleanrooms and manufacturing;

With the increasing demand for certified products, various quality certifications such as ISO checks and National Safety and Quality Health Standards (NSQHS) have been made mandatory for ensuring that the standards for manufacturing processes and products are being upheld. Quality certifications require products to be processed in a cleanroom environment to ensure minimum possible contamination. The need to ensure a sterile and contamination-free environment promotes the greater use of cleanrooms and monitored working areas for manufacturing healthcare products. In addition, the possibility of adverse drug reactions has ensured constant monitoring in the pharmaceutical manufacturing process. According to the FDA, liquid pharmaceutical products labeled for infants and toddlers, offered by leading pharma brands, such as Major Pharmaceuticals and Rugby Laboratories, were recalled in 2017 due to particulate contamination. In the same year, SCA Pharmaceuticals LLC recalled various injectable product lots for possible bacterial contamination. To ensure the highest possible levels of product safety and quality, the focus on effective monitoring has grown with the scale of R&D and manufacturing, and with it, the use of particle counters.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221564539

The Factors such as robust growth in applied markets, the favorable regulatory scenario, and growing focus on the quality of food products are driving the growth of the market during the forecast period.

The airborne particle counters segment accounted for the largest share of the particle counters market.

The airborne particle counters segment accounted for the largest share of the market in 2019. The large market share of this segment can be attributed to the growing monitoring of cleanrooms for the semiconductor, aerospace, pharmaceuticals, and medical devices industries; low cost of remote particle counters; and rising awareness of indoor quality monitoring.

Cleanroom monitoring segment accounted for the largest share of the particle counters applications market in 2019

The cleanroom monitoring segment accounted for the largest share of the particle counter market, by application, in 2019. Technological advancements in industries such as pharmaceutical, medical devices, automotive, and aerospace are increasing the demand for quality assurance and stringent regulations of manufacturing environments to ensure product quality. This has driven the demand for cleanroom monitoring and, by extension, particle counters. Thus, the growth of the market for cleanroom monitoring will be tied directly to the growth of industries that use cleanrooms.

Life sciences & medical device industries are the largest end users of the particle counters market

In 2019, the life sciences & medical device industry segment accounted for the largest share of the market. Market growth is largely driven by the growing volume of compounds to be detected for the presence of impurities in pharmaceutical samples, increasing production of pharmaceutical formulations, stringent safety regulations, and increased R&D expenditure. The increase in pharmaceutical manufacturing outsourcing from the Asian region and the establishment of new manufacturing facilities by global pharmaceutical giants in newer geographies are also propelling the demand for particle counters in this end-user segment.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=221564539

North America to dominate the particle counter market during the forecast period

In 2019, North America accounted for the largest share of the market, followed by Europe. In the US, significant public-private funding and investments to support air pollution monitoring-based researches, faster adoption of technologically advanced particle counters among end users, and strong trend of pharmaceutical and biotechnology research are some of the key factors driving the market for particle counters. Moreover, growing stringent guidelines for pharmaceutical and food products; increasing demand for particle counters in applied markets such as pharmaceuticals, food & beverage, water & environmental monitoring testing; increasing public awareness to enforce strict air pollution monitoring and control regulations, and continuous government expenditure on air pollution monitoring and control are some of the factors expected to drive the growth of the market in Canada during the forecast period.

AS of 2019, prominent players in the particle counters market are Particle Measuring Systems (US), Beckman Coulter (US), RION Co., Ltd. (Japan), Lighthouse Worldwide Solutions (US), TSI (US), Climet Instruments Company (US), Met One Instruments, Inc. (US), Particle Plus (US), Setra Systems (US), PAMAS (Germany), Chemtrac (US), Hal Technology (US), Konamax (US), Veltek Associates (US), PCE Instruments (UK), GrayWolf Sensing Solutions (US), Extech Instruments (US), Palas GmbH (Germany), HYDAC International (Australia), and Fluke Corporation (US), among others

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=221564539

 

Medical Supplies Market | Business Overview, Products and Services, Key Insights, Recent Developments

According to the new market research report “Medical Supplies Market by Type (Diagnostic, Dialysis, Wound Care, Disinfectants, PPE, Radiology, Sterilization, Catheters), Application (Urology, Cardiology, Infection Control), End User (Hospitals, Clinics & Physician Offices) – Global Forecast to 2025″, published by MarketsandMarkets™, is projected to reach USD 133.5 billion by 2025 from USD 132.6 billion in 2020.

Recent Developments:

- In 2020, Baxter launched peri-strips dry with secure grip technology for reliable staple line reinforcement in surgical procedures.

- In 2020, Fresenius Medical Care AG & Co. KGaA inaugurated a EUR 30 million expansion of its transfusion and apheresis disposables plant in the Dominican Republic. The new space includes advanced production equipment, plasma kit assembly lines, and sterilization units that double the cleanroom and storage capacity. The site also includes a large warehouse.

- In 2019, Boston Scientific Corporation acquired BTG plc with a focus on offering best-in-class technologies, unparalleled clinical evidence, and strengthened commercial infrastructure.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64344238

The increasing prevalence of chronic diseases across the globe, increasing government and corporate investments in healthcare projects and infrastructure development, rising demand for infection control measures to curb the occurrence of HAIs, and the rising demand for medical devices are driving the growth of the global medical supplies market. Moreover, the rising medical tourism and emerging markets are expected to offer significant growth opportunities to players operating in the market for coming years.

Catheters accounted for the largest share of the medical supplies market, by type, in 2019

By type, segmented into diagnostic supplies, infusion & injectable supplies, intubation & ventilation supplies, disinfectants, personal protective equipment, sterilization consumables, wound care consumables, dialysis consumables, radiology consumables, catheters, sleep apnea consumables, and other medical supplies. The intubation & ventilation supplies segment is expected to grow at the highest growth rate during the forecast period. The growth of this segment is driven mainly by the rising prevalence of respiratory diseases such as asthma and COPD across the globe.

By application, the other applications segment accounted for the largest market share in 2019

The applications market is categorized into urology, wound care, radiology, respiratory, infection control, cardiology, IVD, and other applications. The other applications segment held the largest market share in 2019, due to factors such as the increasing number of surgical procedures, rising prevalence of dental diseases, and the increasing focus on adhering to proper waste disposal methods.

Hospitals accounted for the largest share of the medical supplies market, by end user, in 2019

The end-user segment of this market is categorized into hospitals, clinics/physician offices, and other end users. Hospitals form the largest and the fastest-growing end-user segment in the medical supply market. This can be attributed to the increasing investments in healthcare systems and the high prevalence of infectious and chronic diseases.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=64344238

North America was the largest regional market for medical supplies in 2019

The global medical supplies market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. The increasing incidence of COVID-19 in the US and the implementation of various supportive initiatives by the Canadian Government are the major factors driving the growth of the market in North America.

The prominent players operating in the global medical supplies market include Medtronic (Ireland), Cardinal Health, Inc. (US), BD (US), Johnson & Johnson (US), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Thermo Fisher Scientific, Inc. (US), Baxter International, Inc. (US), Avanos Medical, Inc. (US), 3M (US), Smith & Nephew (Ireland), ConvaTec Group Plc. (UK), Abbott (US), Cook Medical (US), Merit Medical Systems (US), Stryker (US), Terumo Corporation (Japan), Teleflex Incorporated (US), Fresenius Medical Care AG & Co. KGaA (Germany), and Coloplast Group (Denmark).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=64344238

Cell Dissociation Market | Analysis And Opportunities During Covid-19 Pandemic

According to the new market research report “Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 561 million by 2026 from USD 282 million in 2021, at a CAGR of 14.7%.

Growth opportunities in emerging markets;

The Emerging markets, such as China, India, and Brazil, are expected to offer significant growth opportunities for players operating in the cell dissociation market. These markets are expected to witness high growth in the coming years owing to the increasing R&D activities in the life sciences sector in these countries. For instance, pharmaceutical companies based in India are making significant investments in R&D to introduce new drugs into the market. Cadila Healthcare Ltd., an India-based pharmaceutical company, spent USD 113 million on R&D in 2020, an increase of 13% over 2019. Similarly, Biocon, another India-based pharmaceutical company, spent USD 58.79 million on R&D in 2020, an increase of 52% over 2019. Such investments are expected to increase the demand for cell dissociation products in the country.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97548003

The growth in this market is attributed to the prevalence of cell based research, the increasing number of pharmaceutical and biotechnology companies

Enzymatic dissociation products accounted for the larger share of the cell dissociation market in 2020

Based on the product, the market is segmented Enzymatic dissociation products, Non-Enzymatic dissociation products and instruments. In 2020, the Enzymatic dissociation products segment accounted for the larger share of the market. The large share of this segment can be attributed increasing incidence of cell based research.

By tissue, the connective tissue segment accounted for the largest market share in 2020

Based on the tissue, the market is segmented into connective tissues, epethilial tissues and other tissues (skeletal, muscles tissues). The connective tissues segment accounted for the largest market share in 2020. The increasing incidence attributed to cell based research and development in pharmaceutical and biotechnology companies.

By type, the tissue dissociation segment accounted for the largest market share in 2020

Based on type, the cell dissociation market is segmented into tissue dissociation and cell detachment solution. The tissue dissociation solution segment accounted for the largest market share in 2020. Increasing research and development expenditure in pharmaceutical and biotechnology industries drives segment growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=97548003

Pharmaceutical and biotechnology companies are the largest end-users of the cell dissociation market

Based on end-users, the market is segmented into pharmaceutical and biotechnology companies, research and academic institutes and other end users. The pharmaceutical and biotechnology companies s segment accounted for the largest market share in 2020. The increasing insvestment pharmaceutical and biotechnology is the major driving factors for this market.

North America dominates the global market

Geographically; The cell dissociation market is segmented into four major regional segment, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest share of the market. The large share of North America can primarily be attributed to the increasing research in pharmaceutical and biotechnology industries and the strong presence of major market players in this region.

The major players in the cell dissociation market are Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Cytiva (a part of Danaher Corporation) (US), STEMCELL Technologies (Canada), Miltenyi Biotec (Germany), and PromoCell GmbH (Germany) etc.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=97548003

Growth Of Collagen & Gelatin Market for Regenerative Medicine

According to the new market research report “Collagen and Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular Disease, Dental, Surgical, Dural), End User (Hospitals, Surgical Centers) and Region – Global Forecast to 2026″, published by MarketsandMarkets™, the global bovine collagen market is projected to reach 1,083 million by 2026 from USD 772 million in 2021, at a CAGR of 7.0% during the forecast period.

OPPORTUNITY: Implementation of the 21st Century Cures Act;

The 21st Century Cures Act was signed into law in the US in December 2016. The Act is designed to help accelerate medical product development and bring innovations and advances to patients who need them faster and efficiently. Under this Act, a new Regenerative Medicine Advanced Therapy designation has been established, along with a fast-track approval pathway for new regenerative medicine products. Considering this, the implementation of this Act can potentially result in the approval of new regenerative medicine products in the US and stimulate R&D in the field of regenerative medicine.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95663122

The Growth in the collagen and gelatin market is driven by factors such as the rising prevalence of target diseases and disorders, rising number of surgeries coupled with growing geriatric population, and investments in R&D. However, the availability of efficient and reliable substitute biomaterials is expected to restrain the market growth during the forecast period.

The bovine segment accounted for the largest share of the source segment in the collagen and gelatin market in 2020.

Based on source, the market is segmented into bovine, porcine, and others. The bovine source segment accounted for the largest share of both the collagen market and the gelatin market in 2020. This growth can be attributed to its increased usage in regenerative medicine owing to its high biocompatibility and biodegradability.

The orthopedic segment accounted for the largest share of the application segment in the gelatin market in 2020

Based on application, the global collagen market is segmented into orthopedic, wound care, dental, surgical, cardiovascular, and other applications. The global gelatin market is segmented into orthopedic, wound care, and others. The orthopedic segment accounted for the largest share of both the collagen market and the gelatin market in 2020, mainly due to the increasing use of these biomaterials in orthopedic surgeries and the high demand for scaffolds for bone substitutes.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=95663122

The Asia Pacific region is the fastest-growing region of the collagen market in 2020.

The collagen and gelatin market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in the APAC market is driven by rising geriatric population in Japan and China, increasing prevalence of chronic wounds, and growth in the number of people suffering from pressure ulcers.

Key players in the collagen and gelatin market include Integra LifeSciences (US), Royal DSM (Netherlands), CollPlant Biotechnologies (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions plc (UK), Collagen Matrix, Inc. (US), Symatese (France), GELITA AG (Germany), PB Leiner (Belgium), Smith & Nephew (UK), Zimmer Biomet (US).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=95663122

Wound Care Market: Analysis By Industry Size, Development and Demand Forecast

 According to the new market research report "Wound Care Marketby Product (Dressings (Foam, Film, Hydrocolloid, Collagen, Alginate), Devices (NPWT, Debridement), Grafts, Matrices, Topical Agents, Sutures, Stapler), Wound (Traumatic, Diabetic Ulcers, Surgical, Burn), End User - Global Forecast to 2026", published by MarketsandMarkets™, is projected to reach USD 27.8 billion by 2026 from USD 19.3 billion in 2021, at a CAGR of 7.6% during the forecast period.

Growth Driver: Growing prevalence of diseases & conditions affecting wound healing capabilities;

Physical health conditions, such as acute wounds, chronic wounds, and surgical wounds, have a negative effect on the wound healing process. The prevalence of acute, chronic, and surgical wounds has increased significantly over the past decade, primarily due to the growing global geriatric population, rising traumatic wounds, increasing number of surgeries, and the increasing prevalence of conditions like obesity and diabetes. Diabetes and obesity can result in an increased overall incidence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and chronic wounds, which require treatments (wound management) and incur exorbitant medical expenses.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=371

The market growth is largely driven by factors such as the growing prevalence of chronic conditions resulting in chronic, surgical, acute, and traumatic wounds; increasing spending on chronic wounds; rising use of regenerative medicine in wound management; and technological advancements. The high growth potential of emerging economies and the growing number of acquisitions by key players have also opened an array of opportunities for the growth of the wound care market.

The Surgical & traumatic wounds segment accounted for the largest share of the market, by wound type segment, in 2020

The wound care market, by wound type, is segmented into surgical & traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns & other wounds. In 2020, the surgical & traumatic wounds segment accounted for the largest share in the market. The increasing number of traumatic & surgical wounds is expected to drive the demand for wound care products. The market growth is also largely driven by the rising incidence of diabetes and diabetic foot ulcers due to the high prevalence of pressure ulcers and venous leg ulcers in the geriatric population.

Hospitals & Clinics segment to register the largest share during the forecast period

Based on end users, the wound care market is segmented into hospitals & clinics, long-term care facilities, home care settings, and other end users. In 2020, the hospitals & clinics segment accounted for the largest share of the global market. The large share of this segment can be attributed to factors such as the growing prevalence of surgical and chronic wounds; rising incidence of associated SSIs and HAIs; and the increasing incidence of burn injuries.

Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=371

North America is the largest regional market for wound care market

The global market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2020, North America accounted for the largest market share. The large share of this regional segment can be attributed to the growing prevalence of chronic conditions resulting in chronic, surgical, and traumatic wounds; the increasing incidence of burn injuries; increasing spending on surgical and chronic wounds; and technological advancements in this region.

The major players operating in this wound care market are Smith & Nephew Plc (UK), Mölnlycke Health Care AB (Sweden), Baxter International (US), 3M Company (US), Integra LifeSciences Holdings Corporation (US), ConvaTec Group Plc (UK), Coloplast A/S (Denmark), Medtronic Plc (Ireland), Ethicon Inc. (US), PAUL HARTMANN AG (Germany), MiMedx Group (US), DeRoyal Industries (US), Organogenesis Holdings (US), Kerecis (Iceland), ACell (US), Lohmann & Rauscher International GmbH & Co. (Germany), Medela AG (Switzerland), Talley Group (England), Pensar Medical (US), B. Braun Melsungen AG (Germany), Cardinal Health Inc. (US), Misonix (US), Zimmer Biomet Holdings (US), DermaRite Industries (US), Medline Industries (US), Advancis Medical LLC (UK), MilLaboratories Pvt. Ltd. (India), Welcare Industries Spa. (Italy), Wuhan VSD Medical Science & Technology (China), and Haromed BVBA (Belgium).

Speak to Analyst:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=371